Insights from the murine model and GEMMs suggest that the diverse histotypes observed in human BC may arise from the activation of distinct molecular pathways by Int genes or from alternative oncogenic mechanisms unrelated to insertional mutagenesis. This evidence concerns the gene INTU and breast cancer.